BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20538360)

  • 1. Generating recombinant antibodies to the complete human proteome.
    Dübel S; Stoevesandt O; Taussig MJ; Hust M
    Trends Biotechnol; 2010 Jul; 28(7):333-9. PubMed ID: 20538360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human scFv antibody generation pipeline for proteome research.
    Hust M; Meyer T; Voedisch B; Rülker T; Thie H; El-Ghezal A; Kirsch MI; Schütte M; Helmsing S; Meier D; Schirrmann T; Dübel S
    J Biotechnol; 2011 Apr; 152(4):159-70. PubMed ID: 20883731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant antibodies and in vitro selection technologies.
    Geyer CR; McCafferty J; Dübel S; Bradbury AR; Sidhu SS
    Methods Mol Biol; 2012; 901():11-32. PubMed ID: 22723092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards proteome scale antibody selections using phage display.
    Mersmann M; Meier D; Mersmann J; Helmsing S; Nilsson P; Gräslund S; ; Colwill K; Hust M; Dübel S
    N Biotechnol; 2010 May; 27(2):118-28. PubMed ID: 19883803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives for systematic in vitro antibody generation.
    Konthur Z; Hust M; Dübel S
    Gene; 2005 Dec; 364():19-29. PubMed ID: 16126351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of recombinant antibodies from antibody gene libraries.
    Hust M; Dübel S; Schirrmann T
    Methods Mol Biol; 2007; 408():243-55. PubMed ID: 18314587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of phage libraries for the in vitro production of recombinant monoclonal antibodies of predetermined specificity].
    Flego M; Ascione A; Pini A; Mennella V; Dupuis ML; Benagiano G; Cianfriglia M
    Ann Ist Super Sanita; 2002; 38(4):401-10. PubMed ID: 12760337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of phage display antibody library to MCF-7 cells and screening of single-chain antibodies against breast cancer cells].
    Zhao Y; Wang QM; Fu XQ; Chen JZ; Fan GC; Chen HP
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):667-72. PubMed ID: 15973987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosome display: next-generation display technologies for production of antibodies in vitro.
    He M; Khan F
    Expert Rev Proteomics; 2005 Jun; 2(3):421-30. PubMed ID: 16000087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector.
    Zhao Q; Chan YW; Lee SS; Cheung WT
    Protein Expr Purif; 2009 Dec; 68(2):190-5. PubMed ID: 19683057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimerization domains for antibody phage display and antibody production.
    Thie H; Binius S; Schirrmann T; Hust M; Dübel S
    N Biotechnol; 2009 Dec; 26(6):314-21. PubMed ID: 19631299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully in vitro selection of recombinant antibodies.
    Moutel S; Vielemeyer O; Jin H; Divoux S; Benaroch P; Perez F
    Biotechnol J; 2009 Jan; 4(1):38-43. PubMed ID: 19156724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity reagent resources for human proteome detection: initiatives and perspectives.
    Stoevesandt O; Taussig MJ
    Proteomics; 2007 Aug; 7(16):2738-50. PubMed ID: 17639606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of a human phage display ScFv library against Mycobacterium tuberculosis].
    Yang H; Zhou XG; Shi L; Feng YH; Qin LH; Zheng RJ; Wang J; Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Sep; 31(9):682-5. PubMed ID: 19080570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet integrin alpha2 I-domain specific antibodies produced via domain specific DNA vaccination combined with variable gene phage display.
    Hughes DL; Stafford P; Hamaia SW; Harmer lJ; Schoolmeester A; Deckmyn H; Farndale RW; Ouwehand WH; Watkins NA
    Thromb Haemost; 2005 Dec; 94(6):1318-26. PubMed ID: 16411412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization of anti-mouse prion peptide single chain Fv antibody by phage display].
    Hachisuka A; Koyano S; Kikuchi Y; Nakajima O; Aosasa M; Matsuda H; Sawada J; Teshima R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):26-30. PubMed ID: 20306703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.